CRISPR-Cas
| CRISPR Medicine |
CRISPR-Cas
| CRISPR Medicine |
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Transfusion-Dependent Beta-Thalassemia, TDT, (NCT06041620)
Sponsors:
Institute of Hematology & Blood Diseases Hospital, China
Sponsors:
Institute of Hematology & Blood Diseases Hospital, China
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III